ThetaPal ThetaPal

Manufacturing / Pharmaceutical Preparations

Crinetics Pharmaceuticals, Inc.

CRNX

$83.87

+$0.10 (+0.12%)

Price as of Aug 4, 2026 23:51 UTC

1.9 B

Market Cap (Small Cap)

1%

IV Rank

10.0%

Implied Volatility

Nov 04

Next Earnings

Technical Signals as of Aug 3
Mixed
4 of 7

Trend

  • Above 20-day average $77.44
  • Above 50-day average $62.78
  • Above 200-day average $47.36 ยท +76.9%
  • Moving averages stacked 20 > 50 > 200

Momentum

  • Golden cross (50/200) 18d ago
  • Momentum cross (20/50) 19d ago

Volume

  • Below-average volume 0.2x avg

Price & Trend

Daily candles with EMA 20, SMA 50. Drag to zoom.

Options Activity & Greeks

Implied volatility, flow, and dealer positioning from the options market.

Put/Call Ratio

0.23

Bullish skew

Implied Volatility

10.0%

0% percentile

IV vs Realized

Options cheap

20d HV 199.7%

Options Heat Map

Delta-risk grid for CRNX options across strikes and expirations. Hover any cell for full Greeks.

Loading option chain data...

Insider Trades

0 buys 24 sells
Date Insider Title Type Shares Value
Jul 02, 2026 Vivaldi Coelho Rogerio Sell 3,000 $120,000
Jun 18, 2026 Deardorf Caren Grant 9,730 $0
Jun 18, 2026 Deardorf Caren Grant 5,925 $0
Jun 18, 2026 Nichols Weston Grant 9,730 $0
Jun 18, 2026 Nichols Weston Grant 5,925 $0
Jun 18, 2026 Okey Stephanie Grant 9,730 $0
Jun 18, 2026 Okey Stephanie Grant 5,925 $0
Jun 18, 2026 Vivaldi Coelho Rogerio Grant 9,730 $0
Jun 18, 2026 Vivaldi Coelho Rogerio Grant 5,925 $0
Jun 18, 2026 Fust Matthew K Grant 9,730 $0

Politician Trades in CRNX

Date Politician Party Type Amount
Mar 03, 2026 Gilbert Cisneros Purchase $1K-$15K
Mar 03, 2026 Gil Cisneros D Purchase $1K-$15K
Apr 17, 2025 Gil Cisneros D Purchase $1K-$15K
Mar 19, 2025 Josh S. Gottheimer D Sale $1K-$15K
Jan 29, 2025 Gil Cisneros D Purchase $1K-$15K
Sep 25, 2024 Josh S. Gottheimer D Purchase $1K-$15K

Earnings History

Date Quarter EPS Est. EPS Actual Surprise Result
Aug 04, 2026 Q2 2026 -$1.23

Track CRNX with ThetaPal

Get insider trade alerts, AI portfolio analysis, and options roll recommendations for CRNX and your entire portfolio.